pharma cannabinoids


  By Pat Anson, Editor The U.S. Drug Enforcement Administration has approved a synthetic form of THC (tetrahydrocannabinol) – the active ingredient in marijuana that makes people “high” – as a Schedule II controlled substance. The move is the final regulatory hurdle for dronabinol (Syndros), an oral s Source: DEA […]

DEA Gives Final Approval to Synthetic Marijuana Drug